This Week in PLOS

In PLOS Genetics, researchers from France, the US, and Germany describe a mutation in the KAT2B enzyme-coding gene that appears to broaden the clinical symptoms found in individuals carrying ADD3 mutations implicated in intellectual disability, microcephaly, cataracts, and skeletal defects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.